Sickle cell disease is one of Nigeria’s most urgent yet overlooked health challenges.
The National Health Service (NHS) has approved a groundbreaking £1.65 million treatment for sickle cell disease in England, offering patients a promising 96.6% cure rate.
Nigerians living with sickle cell disease face staggering healthcare costs
U.S FDA has approved two groundbreaking gene therapies targeting sickle cell disease, marking a significant milestone in the realm of CRISPR gene editing technology.
A drug named Crizanlizumab, produced by Novartis has been approved for Sickle Cell treatment in England by the...
